Research Article

Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma

Volume: 51 Number: 4 December 27, 2024
EN

Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma

Abstract

Objective:Rectus sheath hematoma (RSH) is a rare condition characterized by acute abdominal pain and development of a mass on the abdominal wall. It is caused by bleeding resulting from the rupture of one of the inferior epigastric arteries or a tear in the rectus muscle. It is associated with trauma and anticoagulant usage. Although there have been no substantial advancements in the diagnosis and treatment of RSH in recent years, it is anticipated that the incidences of RSH will increase with the rising use of anticoagulants. Surgery is rarely performed, but patients are monitored in general surgery departments. Treatment requires maintaining a delicate balance between the risks of bleeding and thrombosis. This study aims to present nontraumatic RSH cases treated in our clinic, supported by a review of the literature. Methods: This retrospective multicenter study included patients over 18 years of age who were admitted with a diagnosis of nontraumatic RSH between 2020 and 2021 at the Department of General Surgery, Kahramanmaras Sutcu Imam University Faculty of Medicine, and the General Surgery Clinic of Kayseri City Hospital. Patients diagnosed with RSH were identified by reviewing clinical protocol records and digital databases. The demographic data of the patients, such as age and gender, physical examination findings at admission, medications used, comorbidities, complete blood count, international normalized ratio and other laboratory information, imaging methods used for diagnosis, and receipt and quantity of blood products, were recorded. Following diagnosis, patients were monitored for one month for bleeding (recurrent bleeding, gastrointestinal bleeding, and intracranial bleeding) and thrombotic complications (heart valve thrombosis, cerebrovascular events, and pulmonary embolism). Results: Of the 32 patients included in the study, 24 were men (75%) and eight were women (25%). Abdominal pain and palpable swelling were common complaints in all patients. Patient age ranged between 27 and 92 years with a mean age of 70.6 ± 12.9 years. Mean length of hospital stay was 12.6 ± 12.0 days, and 28% of the patients stayed in the intensive care unit for a mean duration of 2.8 ± 6.3 days. Correlation analysis revealed a weak positive correlation between the size of the hematoma on imaging and length of hospital stay and a weak negative correlation between Hb value at diagnosis and length of hospital stay (p = 0.017 and r = 0.426). Conclusion: Nontraumatic RSH is a potentially fatal condition that requires hospitalization and intensive care unit admission as well as substantial amounts of blood transfusion. There is a relationship between the imaging method used at admission and the length of hospital stay as well as the hemoglobin level of the patient.

Keywords

References

  1. 1.Turnage RH, Badgwell B. Abdominal Wall,Umbilicus, Peritoneum, Mesenteries, Omentum, andRetroperitoneum [Internet]. Twenty Fir. SabistonTextbook of Surgery. Elsevier; 2012. 1088–1113 p.Available from: http://dx.doi.org/10.1016/B978-0-323-64062-6.00044-X
  2. 2.Fitzgerald JEF, Fitzgerald LA, Anderson FE,Acheson AG. The changing nature of rectus sheathhaematoma: Case series and literature review. Int JSurg [Internet]. 2009;7(2):150–4. Available from:https://linkinghub.elsevier.com/retrieve/pii/S1743919109000181
  3. 3.Cherry WB, Mueller PS. Rectus Sheath Hematoma.Medicine (Baltimore) [Internet]. 2006 Mar;85(2):105–10. Availablefrom:https://journals.lww.com/00005792-200603000-00005
  4. 4.Jafferbhoy SF, Rustum Q, Shiwani MH. Abdominalcompartment syndrome--a fatal complication from a rectus sheath haematoma. BMJ Case Rep [Internet].2012 Apr 2;2012. Available from:http://www.ncbi.nlm.nih.gov/pubmed/22602838
  5. 5. Sahu KK, Mishra AK, Lal A, George S V, Siddiqui AD. Clinical spectrum, risk factors, management andoutcome of patients with retroperitonealhematoma: a retrospective analysis of 3-yearexperience. Expert Rev Hematol [Internet]. 2020May;13(5):545–55. Available from:http://www.ncbi.nlm.nih.gov/pubmed/32089021
  6. 6.Salemis NS, Gourgiotis S, Karalis G. Diagnosticevaluation and management of patients with rectussheath hematoma. A retrospective study. Int J Surg[Internet]. 2010;8(4):290–3. Available from:http://www.ncbi.nlm.nih.gov/pubmed/20227535 7.Warren MH, Bhattacharya B, Maung AA, Davis KA.Contemporary management of spontaneous retroperitoneal and rectus sheath hematomas. Am JSurg [Internet]. 2020 Apr;219(4):707–10. Availablefrom:http://www.ncbi.nlm.nih.gov/pubmed/31109633
  7. 8.Kunkala MR, Kehl J, Zielinski MD. SpontaneousRectus Sheath Hematomas: When to RestartAnticoagulation? World J Surg [Internet]. 2013 Nov24;37(11):2555–9. Available from: https://onlinelibrary.wiley.com/doi/10.1007/s00268-013-2158-7
  8. 9. Dag A, Ozcan T, Turkmenoglu O, et al. Spontaneousrectus sheath hematoma in patients onanticoagulation therapy. Turkish J TraumaEmergSurg [Internet]. 2011;17(3):210–4. Availablefrom:https://www.journalagent.com/travma/pdfs/UTD-84669-CLINICAL_ARTICLE-DAG.pdf

Details

Primary Language

English

Subjects

Medical Education, Health Services and Systems (Other)

Journal Section

Research Article

Authors

Ali İşler
Türkiye

M. Fatih Yüzbasioglu This is me
Türkiye

Taner Kale
Türkiye

Publication Date

December 27, 2024

Submission Date

July 4, 2024

Acceptance Date

November 6, 2024

Published in Issue

Year 2024 Volume: 51 Number: 4

APA
Topuz, S., Karagöz Eren, S., İşler, A., Bozan, M. B., Muhammedoğlu, B., Yüzbasioglu, M. F., & Kale, T. (2024). Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma. Dicle Medical Journal, 51(4), 477-484. https://doi.org/10.5798/dicletip.1607959
AMA
1.Topuz S, Karagöz Eren S, İşler A, et al. Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma. Dicle Medical Journal. 2024;51(4):477-484. doi:10.5798/dicletip.1607959
Chicago
Topuz, Sezgin, Saliha Karagöz Eren, Ali İşler, et al. 2024. “Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma”. Dicle Medical Journal 51 (4): 477-84. https://doi.org/10.5798/dicletip.1607959.
EndNote
Topuz S, Karagöz Eren S, İşler A, Bozan MB, Muhammedoğlu B, Yüzbasioglu MF, Kale T (December 1, 2024) Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma. Dicle Medical Journal 51 4 477–484.
IEEE
[1]S. Topuz et al., “Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma”, Dicle Medical Journal, vol. 51, no. 4, pp. 477–484, Dec. 2024, doi: 10.5798/dicletip.1607959.
ISNAD
Topuz, Sezgin - Karagöz Eren, Saliha - İşler, Ali - Bozan, Mehmet Buğra - Muhammedoğlu, Bahtiyar - Yüzbasioglu, M. Fatih - Kale, Taner. “Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma”. Dicle Medical Journal 51/4 (December 1, 2024): 477-484. https://doi.org/10.5798/dicletip.1607959.
JAMA
1.Topuz S, Karagöz Eren S, İşler A, Bozan MB, Muhammedoğlu B, Yüzbasioglu MF, Kale T. Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma. Dicle Medical Journal. 2024;51:477–484.
MLA
Topuz, Sezgin, et al. “Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma”. Dicle Medical Journal, vol. 51, no. 4, Dec. 2024, pp. 477-84, doi:10.5798/dicletip.1607959.
Vancouver
1.Sezgin Topuz, Saliha Karagöz Eren, Ali İşler, Mehmet Buğra Bozan, Bahtiyar Muhammedoğlu, M. Fatih Yüzbasioglu, Taner Kale. Timing of Anticoagulation Resumption After Spontaneous Rectus Hematoma. Dicle Medical Journal. 2024 Dec. 1;51(4):477-84. doi:10.5798/dicletip.1607959